ASX Announcements

Filter by Year: 2017 2016 2015 2014 2013
Completion of Phase 2B Trial of MIS416
Grant of Options to Chief Executive Officer
Section 708A Cleansing Statement - Placement
Appendix 3B - Placement
Private Placement to raise Additional Working Capital
Trading Halt
Extracts Re MIS416 Accepted at American Academy Neurologists
Phase 2B Trial of MIS416 on Schedule to Complete April 2017
Change of Director's Interest Notice - Simon Wilkinson
Appendix 3B - Exercise of Employee Options

1 2 Next